A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Pregnant Women at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
Clinical trial NCT03842189 · COMPLETED
Trial details
- NCT number
- NCT03842189
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-05
- Primary completion
- 2024-08-05
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.